AME is a dubious disease in the field of infectious respiratory digestive and endocrine disorders, with clinical performance being complex and often involving multi-system congestion. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of AME requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutically oriented, immune-regulatory therapies and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to the changes in the disease.
The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1. Remote pre-diagnosis: pre-examination of medical records, precise diagnostic directions and medical advice by the team of experts; 2. Interviews in China: arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3.
Full-service: one-stop services: medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.